TUMOUR mutations could be used to predict patients’ responses to cancer treatment drugs, according to the results of a recent study…

Profs Dominique Valla and Tom Hemming Karlsen welcomed the approximately 9,000 delegates from 125 countries, with the former offering some sound advice…

Metabolic and cardiovascular complications are an important burden in patients after liver transplantation (LT) for many reasons, including as a result…

We met with EMJ Hepatology Editorial Board member, Prof Dina Tiniakos, at the ILC, to discuss her career path and her experience at the congress…

This review aims to give an overview and update our knowledge of AATD associated with liver disease and discusses possible new therapeutic strategies…

Among patients with chronic liver disease (CLD), thrombocytopenia (TCP) is a frequent complication.1,2 Before invasive procedures and surgery in CLD…

New imaging modalities are emerging and may potentially replace biopsy. This review discusses the different non-invasive imaging modalities…

The role of angiopoietin 2 (Ang-2) in HCV-related nephropathy and its relationship with platelet parameters and thrombopoietin (TPO) is evaluated in this…

As many as 250,000 Canadians are living with hepatitis C virus (HCV) infection,1 and specific populations, such as people who use drugs (PWUD)…

The NIACE score is an easy-to-calculate  prognostic score, and this study demonstrated that NIACE can distinguish between two subgroups with different…